| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004100 Cardiovascular disorders; kidney disorders; antiinflammatory agents |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050004068 Modulation of tor |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
| 01/06/2005 | US20050004041 Obtained by hydrolysis of casein; hypotensive agents; foods, drugs |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
| 01/06/2005 | US20050003452 Fusion protein comprising membrane translocation sequences for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003029 Treating retinal and choroidal edemas and/or hemorrhages; preserving eyesight |
| 01/06/2005 | US20050003002 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 01/06/2005 | US20050002991 Prophylactic agent of hypertension containing a conjugated fatty acid as an effective ingredient and the use thereof |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/06/2005 | US20050002961 Concentrate comprising green tea, grape skin extract and grape extract, the production thereof and use of the same |
| 01/06/2005 | US20050002933 Proliferation and/or differentiation of stem and progenitor cells from embryo or adult |
| 01/06/2005 | US20050002870 Spray drying; needleless injection |
| 01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | CA2530376A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | CA2529513A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 01/05/2005 | EP1493745A1 New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493740A1 5-fluoro-thiophene compounds, the process for their prepartion, the pharmaceutical compositions containing them and their use as metalloproteinases inhibitors |
| 01/05/2005 | EP1493448A1 Medicinal composition comprising acat inhibitor and insuline resistance improving agent |
| 01/05/2005 | EP1493440A1 Prophylactic agent of hypertension containing a conjugated fatty acid as an effective ingredient and the use thereof |
| 01/05/2005 | EP1493439A1 Means of ascertaining an individual' s risk profile for atherosclerotic disease |
| 01/05/2005 | EP1493034A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2005 | EP1493033A2 Sc6 for diagnosis of hypoxia related conditions |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
| 01/05/2005 | EP1492803A1 New analogs of nitrobenzylthioinosine |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/05/2005 | EP1492792A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492788A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/05/2005 | EP1492787A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
| 01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492769A2 Novel process |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492763A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492569A1 Aqueous dispersible steryl ester compositions |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492547A1 Low-dose potassium supplementation for the prevention and treatment of hypertension |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
| 01/05/2005 | EP1492528A1 Antidiabetic agents |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1492508A1 Controlled release dosage forms |
| 01/05/2005 | EP1411909B1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 01/05/2005 | EP1393067A4 Encapsulated cell indicator system |
| 01/05/2005 | EP1244440B1 Agonists specific for the peripheral cannabinoid receptor |
| 01/05/2005 | EP1227814B1 Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1015449B1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 01/05/2005 | DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 01/05/2005 | DE10325813A1 Prophylaxe und/oder Therapie bei der portalen Hypertonie Prophylaxis and / or therapy of portal hypertension in |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561225A Modulation of leukocyte-endothelial interactions following ischemia |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561205A Use of (R)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 01/05/2005 | CN1561200A Flashmelt oral dosage formulation |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1561197A Method for producing biologically active products |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560076A Derivant with reducing calcium gene related peptide and preparation process thereof |